Bacteriocins and Its Use for Multidrug-Resistant Bacteria Control

Antibiotic Resistance: Mechanisms and New Antimicrobial Approaches

Volumn , Issue , 2016, Pages 329-349

  Preciado, G M ^a   Michel, M M ^a   Villarreal Morales, S L ^a   Flores Gallegos, A C ^a   Aguirre Joya, J ^a   Morlett Chavez J ^a   Aguilar, C N ^a   Rodriguez Herrera R ^a  

^a UNIVERSIDAD AUTÓNOMA DE COAHUILA   (Mexico)

Author keywords

Classification; Diversity; Evolution; Functions; Gram negative; Gram positive; Mechanisms; Structure

Indexed keywords

EID: 84987864220     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-803642-6.00016-2     Document Type: Chapter

References (100)

1. Sahoo T.K., Jena P.K., Patel A.K., Seshadri S. Purification and molecular characterization of the novel highly potent bacteriocin TSU4 produced by Lactobacillus animalis TSU4. Appl Biochem Biotechnol 2015, 177:90-94.
2. Singh N.P., Tiwari A., Bansal A., Thakur S., Sharma G., Gabrani R. Genome level analysis of bacteriocins of lactic acid bacteria. Comput Biol Chem 2015, 56:1-6.
3. Cavera V.L., Arthur T.D., Kashtanov D., Chikindas M.L. Bacteriocins and their position in the next wave of conventional antibiotics. Int J Antimicrob Agents 2015, 1-8. In Press. http://dx.doi.org/10.1016/j.ijantimicag.2015.07.011.
4. Cintas L.M., Casaus M.P., Herranz C., Nes I.F., Hernández P.E. Review: bacteriocins of lactic acid bacteria. Food Sci Technol Int 2001, 7(4):281-305.
5. Rojas C., Vargas P. Bacteriocinas: sustituto de preservantes tradicionales en la industria alimentaria. Tecnol Marcha 2008, 21(2):17.
6. Gálvez A., López R., Pulido L., Pérez R., Burgos M., Grande J. Application of lactic acid bacteria and their bacteriocins for food biopreservation. Food biopreservation 2014, 15-22. Springer, New York, NY, Heidelberg, Dordrecht, and London. R.W. Hartel, D. Rodriguez, P. Clark, D. Topping, J. Finley, Y. Roos (Eds.).
7. Zacharof M.P., Lovitt R.W. Bacteriocins produced by lactic acid bacteria: a review. APCBEE Proc 2012, 2:50-56.
8. Todorov S.D., Prévost H., Lebois M., Dousset X., LeBlanc J.G., Franco B.D. Bacteriocinogenic Lactobacillus plantarum ST16Pa isolated from papaya (Carica papaya)-from isolation to application: characterization of a bacteriocin. Food Res Int 2011, 44(5):1351-1363.
9. Duhan J.S., Nehra K., Gahlawat S.K., Saharan P., Duhan S. Bacteriocins from lactic acid bacteria. Biotechnology. Prospects and applications 2013, 127-141. Springer, New Delhi. R.K. Salar, S.K. Gahlawat, P. Swach, J.S. Duhan (Eds.).
10. Da Silva Sabo S., Vitolo M., González J.M.D., de Souza Oliveira R.P. Overview of Lactobacillus plantarum as a promising bacteriocins producer among lactic acid bacteria. Food Res Int 2014, 64:527-536.
11. Pisano M.B., Fadda M.E., Melis R., Ciusa M.L., Viale S., Deplano M., et al. Molecular identification of bacteriocins produced by Lactococcus lactis dairy strains and their technological and genotypic characterization. Food Control 2015, 51:511-518.
12. Macwana S., Muriana P.M. Spontaneous bacteriocin resistance in Listeria monocytogenes as a susceptibility screen for identifying different mechanisms of resistance and modes of action by bacteriocins of lactic acid bacteria. J Microbiol Methods 2012, 88(1):7-13.
13. Balciunas E.M., Martinez F.A.C., Todorov S.D., de Melo Franco B.D.G., Converti A., de Souza Oliveira R.P. Novel biotechnological applications of bacteriocins: a review. Food Control 2013, 32(1):134-142.
14. Güllüce M., Karadayi M., Bariş O. Bacteriocins: promising natural antimicrobials. Microbial pathogens and strategies for combating them: science, technology and education 2013, 1016-1027. Formatex, Extremadura. A. Méndez-Vilas (Ed.).
15. Gillor O., Kirkup B.C., Riley M.A. Colicins and microcins: the next generation antimicrobials. Adv Appl Microbiol 2004, 54(1):129-146.
16. Bakkal S., Robinson S.M., Ordonez C.L., Waltz D.A., Riley M.A. Role of bacteriocins in mediating interactions of bacterial isolates taken from cystic fibrosis patients. Microbiology 2010, 156:2058-2067.
17. Chavan M.A., Riley M.A. Molecular evolution of bacteriocins in Gram-negative bacteria. Bacteriocins: ecology and evolution 2007, 5-18. Springer, Heidelberg. M.A. Riley, M.A. Chavan (Eds.).
18. Cascales E., Buchanan S.K., Duche D., Kleanthous C., Lloubes R., Postle K., et al. Colicin biology. Microbiol Mol Biol Rev 2007, 71:158-229.
19. Michel-Briand Y., Baysse C. The pyocins of Pseudomonas aeruginosa. Biochimie 2002, 84:499-510.
20. Nakayama K., Takashima K., Ishihara H., Shinomiya T., Kageyama M., Kanaya S., et al. The R-type pyocin of Pseudomonas aeruginosa is related to P2 phage, and the F-type is related to lambda phage. Mol Microbiol 2000, 38:213-231.
21. Heng N.C.K., Wescombe P.A., Burton J.P., Jack R.W., Tagg J.R. The diversity of bacteriocins in Gram-positive bacteria. Bacteriocins: ecology and evolution 2007, 45-83. Springer-Verlag, Berlin and Heidelberg. M.A. Riley, M.A. Chavan (Eds.).
22. Perez R.H., Zendo T., Sonomoto K. Novel bacteriocins from lactic acid bacteria (LAB): various structures and applications. Microb Cell Fact 2014, 13(1):1-13.
23. Yang S.-C., Lin C.-H., Sung C.T., Fang J.Y. Antibacterial activities of bacteriocins: application in foods and pharmaceuticals. Front Microbiol 2014, 5(241):1-10.
24. Thokchom S., Joshi S.R. Probiotic and bacteriocin efficacy of lactic acid bacteria from traditional fermented foods: a review. Assam Univ J Sci Technol 2012, 10(1):142-155.
25. Swetwiwathana A., Visessanguan W. Potential of bacteriocin-producing lactic acid bacteria for safety improvements of traditional Thai fermented meat and human health. Meat Sci 2015, 109:101-105.
26. Bastos M.C.F., Coelho M.L.V., Santos O.C.S. Resistance to bacteriocins produced by Gram-positive bacteria. Microbiology 2015, 161:683-700.
27. Beshkova D., Frengova G. Bacteriocins from lactic acid bacteria: microorganisms of potential biotechnological importance for the dairy industry. Eng Life Sci 2012, 12(4):419-432.
28. Hassan M., Kjos M., Nes I.F., Diep D.B., Lotfipour F. Natural antimicrobial peptides from bacteria: characteristics and potential applications to fight against antibiotic resistance. J Appl Microbiol 2012, 113:723-736.
29. Lim S.M. Anti-Helicobacter pylori activity of antimicrobial substances produced by lactic acid bacteria isolated from Baikkimchi. J Korean Soc Appl Biol Chem 2014, 57:621-630.
30. Hamilton-Miller J.M. The role of probiotics in the treatment and prevention of Helicobacter pylori infection. Int J Antimicrob Agents 2003, 22:360-366.
31. Ukeyima M.T., Enujiugha V.N., Sanni T.A. Current applications of probiotic foods in Africa. Afr J Biotechnol 2010, 9:394-401.
32. De Bortoli N., Leonard G., Ciancia E., Merlo A., Bellini M., Costa F., et al. Helicobacter pylori eradication: a randomized, prospective study of triple therapy versus triple therapy plus lactoferrin and probiotics. Am J Gastroenterol 2007, 102:951-966.
33. Malfertheiner P., Mgraud F., O'Morain C., Bazzoli F., El-Omar E., Graham D., et al. Current concepts in the management of Helicobacter pylori infection. Aliment Pharmacol Ther 2002, 16:167-180.
34. Lü X., Yi L., Dang J., Dang Y., Liu B. Purification of novel bacteriocin produced by Lactobacillus coryniformis MXJ 32 for inhibiting bacterial foodborne pathogens including antibiotic-resistant microorganisms. Food Control 2014, 46:264-271.
35. Acuña L., Picariello G., Sesma F., Morero R., Augusto A. A new hybrid bacteriocin, Ent35-MccV, displays antimicrobial activity against pathogenic Gram-positive and Gram-negative bacteria. FEBS Open Bio 2012, 2:12-19.
36. Acuña L., Corbalan N.S., Fernandez-No I.C., Morero R.D., Barros-Velazquez J., Bellomio A. Inhibitory effect of the hybrid bacteriocin Ent35-MccV on the growth of Escherichia coli and Listeria monocytogenes in model and food systems. Food Bioprocess Technol 2015, 8:1063-1075.
37. Zhao L., Wang Y., Wang S., Li H., Huang W., Liao X. Inactivation of naturally occurring microbiota in cucumber juice by pressure treatment. Int J Food Microbiol 2014, 174:12-18.
38. Belgeri A., Adkins S.W. Allelopathic potential of invasive parthenium weed (Parthenium hysterophorus L.) seedlings on grassland species in Australia. Allelopathy J 2015, 36(1):1-14.
39. Braun V., Pilsl H., Groß P. Colicins: structures, modes of actions, transfer through membranes, and evolution. Arch Microbiol 1994, 161:199-206.
40. Riley M.A., Wertz J.E. Bacteriocins: evolution, ecology and application. Annu Rev Microbiol 2002, 56:117-137.
41. Riley M.A., Gordon D.M. A survey of col plasmids in natural isolates of Escherichia coli and an investigation into the stability of col-plasmid lineages. J Gen Microbiol 1992, 138:1345-1352.
42. Riley M.A. Bacteriocins, biology, ecology, and evolution. Encyclopedia of microbiology 2009, 32-44. Elsevier, Oxford. M. Schaechter (Ed.).
43. Osborne M., Lian L., Wallis R., Reilly A., James R., Kleanthous C., et al. Sequential assignments and identication of secondary structure elements of the colicin E9 immunity protein in solution by homonuclear and heteronuclear NMR. Biochemistry 1994, 33:12347-12355.
44. Viejo M., Gargallo D., Ferrer S., Enfedaque J., Regue M. Cloning and DNA sequence analysis of a bacteriocin gene of Serratia marcescens. J Gen Microbiol 1992, 138:1737-1743.
45. Riley M.A., Cadavid M., Collett M., Neely M., Adams M., Philips C., et al. The newly characterized colicin Y provides evidence of positive selection in pore-former colicin diversification. Microbiology 2000, 146:1671-1677.
46. Tan Y., Riley M.A. Nucleotide polymorphism in colicin E2 gene clusters: evidence for non-neutral evolution. Mol Biol Evol 1997, 14:666-673.
47. Kuroda K., Kageyama M. Comparative study of F-type pyocins of Pseudomonas aeruginosa. J Biochem 1981, 89:1721-1736.
48. Torreblanca M., Meseguer I., Ventosa A. Production of halocin is a practically universal feature of archaeal halophilic rods. Lett Appl Microbiol 1994, 19:201-205.
49. Jack R.W., Tagg J.R., Ray B. Bacteriocins of Gram-positive bacteria. Microbiol Rev 1995, 59:171-200.
50. Shand R., Price L., O'Connor Halocins: protein antibiotics from hypersaline environments. Microbiology and biogeochemistry of hypersaline environments 1998, 297-304. CRC Press, Boca Raton, FL. A. Oren, F.L.B. Raton (Eds.).
51. Gutiérrez J., Larsen R., Cintas L.M., Kok J., Hernández P.E. High-level heterologous production and functional expression of the sec-dependent enterocin P from Enterococcus faecium P13 in Lactococcus lactis. Appl Microbiol Biotechnol 2006, 17:1-11.
52. Van Reenen C.A., Chikindas M.L., Van Zyl W.H., Dicks L.M.T. Characterization and heterologous expression of a class IIa bacteriocin, plantaricin 423 from Lactobacillus plantarum 423 in Saccharomyces cerevisiae. Int J Food Microbiol 2003, 81:29-40.
53. Hastings J.W., Sailer M., Johnson K., Roy K.L., Vederas J.C., Stiles M.E. Characterization of leucocin A-UAL 187 and cloning of the bacteriocin gene from Leuconostoc gelidum. J Bacteriol 1991, 73:7491-7500.
54. Fimland G., Sletten K., Nissen-Meyer J. The complete amino acid sequence of the pediocin-like antimicrobial peptide leucocin C. Biochem Biophys Res Commun 2002, 295:826-827.
55. Blom H., Katla T., Holck A., Sletten K., Axelsson L., Holo H. Characterization, production and purification of leucocin H, a two-peptide bacteriocin from Leuconostoc MF215B. Curr Microbiol 1999, 39:43-48.
56. Masuda Y., Ono H., Kitagawa H., Ito H., Mu F., Sawa N., et al. Identification and characterization of leucocyclicin Q, a novel cyclic bacteriocin produced by Leuconostoc mesenteroides TK41401. Appl Environ Microbiol 2011, 77:8164-8170.
57. Wan X., Saris P.E.J., Takala T.M. Genetic characterization and expression of leucocin B, a class IId bacteriocin from Leuconostoc carnosum 4010. Res Microbiol 2015, 166:494-503.
58. Hechard Y., Derijard B., Letellier F., Cenatiempo Y. Characterization and purification of mesentericin Y105, an anti-Listeria bacteriocin from Leuconostoc mesenteroides. J Gen Microbiol 1992, 138:2725-2731.
59. Hechard Y., Berjeaud J.M., Cenatiempo Y. Characterization of the mesB gene and expression of bacteriocins by Leuconostoc mesenteroides Y105. Curr Microbiol 1999, 39:265-269.
60. Ennahar S., Sashihara T., Sonomoto K., Ishizaki A. Class IIa bacteriocins: biosynthesis, structure and activity. FEMS Microbiol Rev 2000, 24:85-106.
61. Biet F., Berjeaud J.M., Worobo R.W., Cenatiempo Y., Fremaux C. Heterologous expression of the bacteriocin mesentericin Y105 using the dedicated transport system and the general secretion pathway. Microbiology 1998, 144:2845-2854.
62. Chikindas M.L., Venema K., Ledeboer A.M., Venema G., Kok J. Expression of lactococcin A and pediocin PA-1 in heterologous hosts. Lett Appl Microbiol 1995, 21:183-189.
63. Morisset D., Frére J. Heterologous expression of bacteriocins using the mesentericin Y105 dedicated transport system by Leuconostoc mesenteroides. Biochimie 2002, 84:569-576.
64. Gutiérrez J., Criado R., Citti R., Martín M., Herranz C., Nes I.F. Cloning, production and functional expression of enterocin P, a sec-dependent bacteriocin produced by Enterococcus faecium P13, in Escherichia coli. Int J Food Microbiol 2005, 103:239-250.
65. Kittikun H., Biscola A., El-Ghaish V., Jaffrès S., Dousset E., Pillot G., et al. Bacteriocin-producing Enterococcus faecalis KT2W2G isolated from mangrove forests in southern Thailand: purification, characterization and safety evaluation. Food Control 2015, 54:126-134.
66. An J., Zhu W., Liu Y., Zhang X., Sun L., Hong P., et al. Purification and characterization of a novel bacteriocin CAMT2 produced by Bacillus amyloliquefaciens isolated from marine fish Epinephelus areolatus. Food Control 2015, 51:278-282.
67. Ghanbari M., Jami M., Kneifel W., Domig K.J. Antimicrobial activity and partial characterization of bacteriocins produced by lactobacilli isolated from Sturgeon fish. Food Control 2013, 32(2):379-385.
68. Deegan L.H., Cotter P.D., Hill C., Ross P. Bacteriocins: biological tools for biopreservation and shelf-life extension. Int Dairy J 2006, 16:1058-1071.
69. Sharma N., Kapoor R., Gautam N., Kumari R. Purification and characterization of bacteriocin produced by Bacillus subtilis R75 isolated from fermented chunks of mung bean. Food Technol Biotech 2011, 49:169-176.
70. Samelis J., Bleicher A., Delbes-Paus C., Kakouri A., Neuhaus K., Montel M.C. FTIR-based polyphasic identification of lactic acid bacteria isolated from traditional Greek Graviera cheese. Food Microbiol 2010, 28:76-83.
71. Siragusa G.R., Cutter C.N., Willett J.L. Incorporation of bacteriocin in plastic retains activity and inhibits surface growth of bacteria on meat. Food Microbiol 1999, 16:229-235.
72. Chen H., Hoover D.G. Bacteriocins and their food applications. Compr Rev Food Sci Food Saf 2003, 2:82-100.
73. Ercolini D., Storia A., Villani F., Mauriello G. Effect of a bacteriocin activated polythene film on Listeria monocytogenes as evaluated by viable staining and epifluorescence microscopy. J Appl Microbiol 2006, 100:765-772.
74. Settanni L., Corsetti A. Application of bacteriocins in vegetable food biopreservation. Int J Food Microbiol 2008, 31:123-138.
75. Ercolini D., Ferrocino I., La Storia A., Mauriello G., Gigli S., Masi P., et al. Development of spoilage microbiota in beef stored in nisin activated packaging. Food Microbiol 2010, 27:137-143.
76. Simha B.V., Sood S.K., Kumariya R., Garsa A.K. Simple and rapid purification of pediocin PA-1 from Pediococcus pentosaceous NCDC 273 suitable for industrial application. Microbiol Res 2012, 167(9):544-549.
77. Danisco. Antimicrobials.; 2013 [accessed 13.09.13]. http://www.danisco.com/product-range/antimicrobials/.
78. Daview E.A., Bevis H.E., Delves-Broughton J. The use of the bacteriocin, nisin, as a preservative in ricotta type cheeses to control the food-borne pathogen Listeria monocytogenes. Lett Appl Microbiol 1997, 24:343-346.
79. Snyder A.B., Worobo R.W. Chemical and genetic characterization of bacteriocins: antimicrobial peptides for food safety. J Sci Food Agric 2013, 94:28-44.
80. Magiorakos A.P., Srinivasan A., Carey R.B., Carmeli Y., Falagas M.E., Giske C.G., et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 2012, 3:268-281.
81. Falagas M.E., Karageorgopoulos D.E. Pandrug resistance (PDR), extensive drug resistance (XDR), and multidrug resistance (MDR) among Gram-negative bacilli: need for international harmonization in terminology. Clin Infect Dis 2008, 46:1121-1122.
82. Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs-Worldwide, 2000-2004. MMWR Morb Mortal Wkly Rep 2006, 55:301-305. CDC.
83. Kuo L.C., Teng L.J., Yu C.J., Ho S.W., Hsueh P.R. Dissemination of a clone of unusual phenotype of pan drug-resistant Acinetobacter baumannii at a university hospital in Taiwan. J Clin Microbiol 2004, 42:1759-1763.
84. Notice to readers: revised definition of extensively drug-resistant tuberculosis. MMWR Morb Mortal Wkly Rep 2006, 55:1176. CDC.
85. Freire-Morana L., Aronssona B., Manz C., Gyssensc I.C., Sob A.D., Monnete D.L., et al. Critical shortage of new antibiotics in development against multidrug-resistant bacteria-time to react is now. Drug Resist Updat 2011, 14:118-124.
86. WHO. World Health Organization.; 2015 [accessed 15.09.15]. http://www.who.int/mediacentre/news/releases/2010/drug_resistant_tb_20100318/es/.
87. Rath S., Padhy N. Monitoring in vitro antibacterial efficacy of Terminalia alata Heyne ex. Roth, against MDR enteropathogenic bacteria isolated from clinical samples. J Acute Med 2013, 3:93-102.
88. Toussaint K.A., Gallagher J.C. Beta-lactam/beta-lactamase inhibitor combinations: from then to now. Ann Pharmacother 2015, 49:86-88.
89. Lucasti C., Popescu I., Ramesh M.K., Lipka J., Sable C. Comparative study of the efficacy and safety of ceftazidime/avibactam plus metronidazole versus meropenem in the treatment of complicated intra-abdominal infections in hospitalized adults: results of a randomized, double-blind, Phase II trial. J Antimicrob Chemother 2013, 68:1183-1192.
90. Viale P., Giannella M., Tedeschi S., Lewis R. Treatment of MDR-Gram negative infections in the 21st century: a never ending threat for clinicians. Curr Opin Pharmacol 2015, 24:30-37.
91. Cotter P.D., Ross R.P., Hill C. Bacteriocins a viable alternative to antibiotics?. Nat Rev Microbiol 2013, 11:95-105.
92. Allen H.K., Trachsel J., Looft T., Casey T.A. Finding alternatives to antibiotics. Ann NY Acad Sci 2014, 1323:91-100.
93. Amer E.I., Mossallam S.F., Mahrous H. Therapeutic enhancement of newly derived bacteriocins against Giardia lamblia. Exp Parasitol 2014, 146:52-53.
94. Lancaster L.E., Wintermeyer W., Rodnina M.V. Colicins and their potential in cancer treatment. Blood Cells Mol Dis 2007, 38:15-18.
95. Rea M.C., Ross R.P., Cotter P.D., Hill C. Classification of bacteriocins from Gram-positive bacteria. Prokaryotic antimicrobial peptides: from genes to applications 2011, 29-49. Springer, New York, NY. D. Drider, S. Rebuffat (Eds.).
96. Millet M., Cornut G., Dupont C., Shareck F., Archambault D., Lacroix M. Capacity of human nisin and pediocin-producing LAB to reduce vancomycin-resistant Enterococci (VRE) intestinal colonization. Appl Environ Microbiol 2008, 74:1997-2003.
97. Ruiz F.O., Pascual L., Giordano W., Barberis L. Bacteriocins and other bioactive substances of probiotic lactobacilli as biological weapons against Neisseria gonorrhoeae. FEMS Pathog Dis 2015, 73(3):1-10.
98. Kaur G., Singh T.P., Malik R.K., Bhardwaj A., De S. Antibacterial efficacy of nisin, pediocin 34 and enterocin FH99 against L. monocytogenes, E. faecium and E. faecalis and bacteriocin cross resistance and antibiotic susceptibility of their bacteriocin resistant variants. J Food Sci 2014, 51(2):233-244.
99. Gutiérrez-Chávez A.J., Martínez-Ortega E.A., Valencia-Posadas M., León-Galván M.F., de la Fuente-Salcido N.M., Bideshi D.K., et al. Potential use of Bacillus thuringiensis bacteriocins to control antibiotic-resistant bacteria associated with mastitis in dairy goats. Folia Microbiol (Praha) 2015, 60(3):1-9.
100. Le Marrec C., Hyronimus B., Bressolier P., Verneuil B., Urdaci M.C. Biochemical and genetic characterization of coagulin, a new antilisterial bacteriocin in the pediocin family of bacteriocins, produced by Bacillus coagulans I. Appl Environ Microbiol 2000, 66:5213-5220.